Earlier this month, more than 70 Democrats in the House introduced a resolution asking the Food and Drug Administration (FDA) to permanently lift in-person requirements for chemical-abortion drugs.
Over the past year and a half, supporters of legal abortion have used the COVID-19 pandemic to expand access to chemical abortion. In 2020, pro-abortion groups litigated against existing FDA rules, which had required that chemical abortions take place under medical supervision. While those abortion proponents received a favorable ruling from a U.S. district court judge in July of last year, the Supreme Court ruled this past January that the FDA’s protective rules could remain in place.
But in April, under the direction of the Biden administration, the FDA lifted existing restrictions on telemedicine abortions for the duration of the COVID-19 pandemic.